Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Cognitive Therapy01:25

Cognitive Therapy

1.6K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.6K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

887
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
887
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Beck's Cognitive Therapy01:25

Beck's Cognitive Therapy

621
Cognitive therapy is a psychological approach designed to address distortions in thinking, which can lead to negative emotions and unrealistic beliefs. These cognitive distortions often influence how individuals interpret and respond to situations, exacerbating emotional distress. Below are some prevalent cognitive distortions, their characteristics, and examples of how they manifest in thought processes.
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...
621
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study.

Psychiatric research and clinical practice·2022
Same author

BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained Warping.

Brain connectivity·2022
Same author

Circulating microRNA associated with future relapse status in major depressive disorder.

Frontiers in psychiatry·2022
Same author

Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response.

Biological psychiatry·2022
Same author

Alterations in resting-state functional activity and connectivity for major depressive disorder appetite and weight disturbance phenotypes.

Psychological medicine·2022
Same author

Youth Aware of Mental Health (YAM) Program With Texas Adolescents: Depression, Anxiety, and Substance Use Outcomes.

The Journal of clinical psychiatry·2022

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K

Cognitive dysfunction in unipolar depression: implications for treatment.

Madhukar H Trivedi1, Tracy L Greer

  • 1Division of Mood Disorders, UT Southwestern Medical Center, Dallas, TX, United States.

Journal of Affective Disorders
|November 13, 2013
PubMed
Summary
This summary is machine-generated.

Major depressive disorder (MDD) is linked to early cognitive deficits and neural abnormalities, impacting recovery. New treatments targeting cognitive symptoms are crucial for improved long-term functional outcomes in MDD patients.

Keywords:
Antidepressant treatmentFunctional impairmentMajor depressive disorder (MDD)Neurocognition

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

747
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

9.7K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

747
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

9.7K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Science

Background:

  • Major depressive disorder (MDD) is characterized by mood disturbances, but also significant cognitive impairments.
  • These cognitive deficits, including issues with memory and executive function, are often present early in the illness course.
  • Early cognitive abnormalities in MDD may be associated with structural changes in brain regions vital for cognition, such as the hippocampus and prefrontal cortex.

Purpose of the Study:

  • To review existing literature on early neural circuitry and cognitive abnormalities in major depressive disorder (MDD).
  • To assess the impact of these early features on treatment selection and long-term patient outcomes.
  • To identify the need for novel therapeutic strategies targeting cognitive dysfunction in MDD.

Main Methods:

  • Systematic literature search of PubMed/Medline for peer-reviewed English articles.
  • Keywords included major depressive disorder, unipolar depression, first episode, early, cognition, executive function, and memory.
  • Selection criteria focused on 12 studies, systematic reviews, and meta-analyses evaluating cognitive functions in individuals with MDD.

Main Results:

  • Cognitive deficits in memory and decision-making are prevalent early in MDD, often accompanied by structural brain abnormalities.
  • Patient-reported symptoms like difficulty concentrating and indecisiveness can hinder functional recovery.
  • While some cognitive symptoms may improve with antidepressants, they can also persist, indicating a need for targeted interventions.

Conclusions:

  • Cognitive symptoms in MDD often lag behind mood symptom recovery and can persist residually.
  • Current treatment approaches may not sufficiently address early cognitive deficits in major depressive disorder.
  • Developing new strategies that target both mood and cognitive symptoms is essential for enhancing functional recovery and long-term outcomes in MDD.